Literature DB >> 30354717

Prognostic Value of Masked Uncontrolled Hypertension.

Sante D Pierdomenico1, Anna M Pierdomenico2, Francesca Coccina2, Denis L Clement3, Marc L De Buyzere3, Dirk A De Bacquer4, Iddo Z Ben-Dov5, Wanpen Vongpatanasin6, José R Banegas7, Luis M Ruilope7, Lutgarde Thijs8, Jan A Staessen8,9.   

Abstract

The prognostic relevance of masked uncontrolled hypertension (MUCH) is incompletely clear, and its global impact on cardiovascular outcomes and mortality has not been assessed. The aim of this study was to perform a meta-analysis on the prognostic value of MUCH. We searched for articles assessing outcome in patients with MUCH compared with those with controlled hypertension (CH) and reporting adjusted hazard ratio and 95% CI. We identified 6 studies using ambulatory blood pressure monitoring (12 610 patients with 933 events) and 5 using home blood pressure measurement (17 742 patients with 394 events). The global population included 30 352 patients who experienced 1327 events. Selected studies had cardiovascular outcomes and all-cause mortality as primary outcome, and the main result is a composite of these events. The overall adjusted hazard ratio was 1.80 (95% CI, 1.57-2.06) for MUCH versus CH. Subgroup meta-analysis showed that adjusted hazard ratio was 1.83 (95% CI, 1.52-2.21) in studies using ambulatory blood pressure monitoring and 1.75 (95% CI, 1.38-2.20) in those using home blood pressure measurement. Risk was significantly higher in MUCH than in CH independently of follow-up length and types of studied events. MUCH was at significantly higher risk than CH in all ethnic groups, but the highest hazard ratio was found in studies, including black patients. Risk of cardiovascular events and all-cause mortality is significantly higher in patients with MUCH than in those with CH. MUCH detected by ambulatory or home blood pressure measurement seems to convey similar prognostic information.

Entities:  

Keywords:  blood pressure; hypertension; masked hypertension; mortality; risk

Mesh:

Year:  2018        PMID: 30354717      PMCID: PMC6205750          DOI: 10.1161/HYPERTENSIONAHA.118.11499

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  45 in total

Review 1.  Masked hypertension: a phenomenon of measurement.

Authors:  Stanley S Franklin; Eoin O'Brien; Lutgarde Thijs; Kei Asayama; Jan A Staessen
Journal:  Hypertension       Date:  2014-10-06       Impact factor: 10.190

2.  'Reverse white-coat hypertension' in older hypertensives.

Authors:  Lindon M H Wing; Mark A Brown; Lawrence J Beilin; Philip Ryan; Christopher M Reid
Journal:  J Hypertens       Date:  2002-04       Impact factor: 4.844

3.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

4.  Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).

Authors:  R Sega; G Trocino; A Lanzarotti; S Carugo; G Cesana; R Schiavina; F Valagussa; M Bombelli; C Giannattasio; A Zanchetti; G Mancia
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality.

Authors:  José R Banegas; Luis M Ruilope; Alejandro de la Sierra; Ernest Vinyoles; Manuel Gorostidi; Juan J de la Cruz; Gema Ruiz-Hurtado; Julián Segura; Fernando Rodríguez-Artalejo; Bryan Williams
Journal:  N Engl J Med       Date:  2018-04-19       Impact factor: 91.245

Review 6.  Masked hypertension: understanding its complexity.

Authors:  Stanley S Franklin; Eoin O'Brien; Jan A Staessen
Journal:  Eur Heart J       Date:  2017-04-14       Impact factor: 29.983

7.  Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study.

Authors:  Roberto Minutolo; Francis B Gabbai; Rajiv Agarwal; Paolo Chiodini; Silvio Borrelli; Vincenzo Bellizzi; Felice Nappi; Giovanna Stanzione; Giuseppe Conte; Luca De Nicola
Journal:  Am J Kidney Dis       Date:  2014-07-28       Impact factor: 8.860

8.  Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.

Authors:  Danielle Tientcheu; Colby Ayers; Sandeep R Das; Darren K McGuire; James A de Lemos; Amit Khera; Norman Kaplan; Ronald Victor; Wanpen Vongpatanasin
Journal:  J Am Coll Cardiol       Date:  2015-11-17       Impact factor: 24.094

9.  High prevalence of masked uncontrolled hypertension in people with treated hypertension.

Authors:  José R Banegas; Luis M Ruilope; Alejandro de la Sierra; Juan J de la Cruz; Manuel Gorostidi; Julián Segura; Nieves Martell; Juan García-Puig; John Deanfield; Bryan Williams
Journal:  Eur Heart J       Date:  2014-02-03       Impact factor: 29.983

10.  Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study.

Authors:  Toshio Kushiro; Kazuomi Kario; Ikuo Saito; Satoshi Teramukai; Yuki Sato; Yasuyuki Okuda; Kazuyuki Shimada
Journal:  Hypertens Res       Date:  2016-08-11       Impact factor: 3.872

View more
  20 in total

Review 1.  Phosphate, the forgotten mineral in hypertension.

Authors:  Han-Kyul Kim; Masaki Mizuno; Wanpen Vongpatanasin
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

2.  Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.

Authors:  Mohammed Siddiqui; Eric K Judd; Tanja Dudenbostel; Bin Zhang; Pankaj Gupta; Maciej Tomaszewski; Prashanth Patel; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2019-07-22       Impact factor: 10.190

3.  Sex differences in masked hypertension: the Coronary Artery Risk Development in Young Adults study.

Authors:  Daniel N Pugliese; John N Booth; Luqin Deng; D Edmund Anstey; Natalie A Bello; Byron C Jaeger; James M Shikany; Donald Lloyd-Jones; Cora E Lewis; Joseph E Schwartz; Paul Muntner; Daichi Shimbo
Journal:  J Hypertens       Date:  2019-12       Impact factor: 4.844

4.  Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.

Authors:  Panagiotis I Georgianos; Vassilios Liakopoulos; Pantelis E Zebekakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-24       Impact factor: 3.738

5.  Proportion of US Adults Recommended Out-of-Clinic Blood Pressure Monitoring According to the 2017 Hypertension Clinical Practice Guidelines.

Authors:  John N Booth; Demetria Hubbard; Swati Sakhuja; Yuichiro Yano; Paul K Whelton; Jackson T Wright; Daichi Shimbo; Paul Muntner
Journal:  Hypertension       Date:  2019-06-24       Impact factor: 10.190

6.  The further development of out-of-office BP monitoring: Japan's ImPACT Program Project's achievements, impact, and direction.

Authors:  Kazuomi Kario; Naoko Tomitani; Hiroshi Kanegae; Nobuhiko Yasui; Ryozo Nagai; Hiroshi Harada
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-27       Impact factor: 3.738

7.  Prognostic value of daytime and nighttime blood pressure in treated hypertensive patients according to age and sex.

Authors:  Francesca Coccina; Anna M Pierdomenico; Jacopo Pizzicannella; Umberto Ianni; Gabriella Bufano; Rosalinda Madonna; Oriana Trubiani; Francesco Cipollone; Sante D Pierdomenico
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-10       Impact factor: 3.738

8.  Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion.

Authors:  Mohammed Siddiqui; Eric K Judd; Bin Zhang; Tanja Dudenbostel; Robert M Carey; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2020-12-07       Impact factor: 10.190

9.  Office, Central, and Ambulatory Blood Pressure for Predicting First Stroke in Older Adults: A Community-Based Cohort Study.

Authors:  Kenji Matsumoto; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Joseph E Schwartz; Tatjana Rundek; Carlo Mannina; Kazato Ito; Ralph L Sacco; Marco R Di Tullio
Journal:  Hypertension       Date:  2021-07-12       Impact factor: 9.897

10.  Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.

Authors:  Stanford E Mwasongwe; Rikki M Tanner; Bharat Poudel; Daniel N Pugliese; Bessie A Young; Marwah Abdalla; Solomon K Musani; Orlando M Gutiérrez; Adolfo Correa; Daichi Shimbo; Paul Muntner
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-26       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.